Kolkata (West Bengal) [India], August 29 (ANI): West Bengal Chief Minister Mamta Banerjee on Monday accused the Bharatiya Janata Party (BJP) of misusing probe agencies and claimed a media trial was on in important cases.
Pokhran (Rajasthan) [India], August 29 (ANI): Trials of the Made-in-India enhanced Pinaka Rockets were successfully conducted at Balasore and Pokhran over the past few weeks, Defence Research and Development Organisation (DRDO) officials said on Monday.
Washington [US], August 29 (ANI): At this year's MTV VMAs Hollywood star Johnny Depp marked his presence as the Moon Person, popping in for a few one-liners at the awards show.
Ruby earned a nerve-wracking 24-23 victory over state-mate Simranpreet Kaur Brar. She had qualified fourth with a score of 578 in the first round, while Simranpreet was fifth with 577. In the top-eight semi-final stage, Simranpreet topped the first semis with a score of 13 to make the finals
Bengaluru (Karnataka) [India], August 26 (ANI/NewsVoir): Smytten, India's largest tech-enabled D2C product discovery & trial platform, launches India's first-ever concept of 'Makeup - Try At Home' that offers a wide selection of trial size miniature makeup products from the best of brand
Kolkata (West Bengal) [India], August 26 (ANI): West Bengal Chief Minister Mamata Banerjee on Thursday said that there shouldn't be media trials as they mislead.
Rhythm finished on top of the 93-woman qualification field with a score of 585 after her allotted 60-shots. Abhidnya was fifth with 577 and Naamya sixth with 575. Abhidnya did finish ahead of Rhythm in the semis (on countback) with 11 hits each but was no match for her in the final.
Costa Mesa (California) [United States], August 24 (ANI/PRNewswire): eQ Technologic, the providers of the eQube®-DaaS (Data as a Service) Platform, announced earlier today the launch of a new format in which their products can be accessed: a next-gen cloud-native solution for data/appli
Geneva [Switzerland], August 24 (ANI/PRNewswire): The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial evaluating SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon. This milestone follows Investigational Device Exemption (IDE) approv
Washington [US], August 23 (ANI): Children who suffer a relapse of aggressive cancer known as neuroblastoma have small chances of survival. However, researchers have now shown that DHODH blockers, which are well-tolerated in humans, can cure neuroblastoma in mice if administered in combinati